CORPORATE SUPPORT

The support of ACUTE LEUKEMIAS XVII by the following companies is gratefully acknowledged:

Platin Circle Corporate Members (alphabetical order):

Abbvie Deutschland GmbH
SAT I: Sunday, March 19, 2023
€ 25.000

Industrial Exhibition
€ 9.000

Screen Advertisement
Sunday, Monday, Tuesday, March 19-21, 2023
€ 4.000

Link to AbbVie website
€ 1.000

Ad in Annals of Hematology
€ 1.500

12 HCPs
€ 2.640

Brisol Myers Squibb
SAT II: Monday, March 20, 2023
€ 25.000

Bristol Myers Squibb
Symposium Proceedings
€ 20.000

Gold Circle Corporate Members (alphabetical order):

		Pfizer GmbH SAT VIII: Tuesday, Feb 26, 2019 € 25.000

		Jazz Pharmaceuticals Germany GmbH SAT III: Monday, Feb 25, 2019 € 22.000

Silver Circle Corporate Members (alphabetical order):

		Astellas Pharma MTP Session III: Tuesday, March 21, 2023 € 18.750

		Novartis Pharma GmbH MTP Session III: Tuesday, March 21, 2023 € 18.750

		Servier Laboratories MTP I: Monday, March 20, 2023 € 18.750

Bronze Corporate Members (alphbetical order):

		BeiGene Insutrial Exhbition € 4.800

		Gilead Sciences GmbH Screen Advertisement Sunday, March 19, Monday, March 20, 2023 € 1.000 2 Poster Prizes € 1.000

		Mission Bio Industrial Exhibition € 4.800

		Otsuka Industrial Exhibition € 2.400

		Servier Deutschland Industrial Exhibition € 3.500

		Neovii Industrial Exhibition € 2.400

The support of the international symposium ACUTE LEUKEMIAS XVIII (ISALXVIII) March 19-22, 2023 by the following third-party donors is gratefully acknowledged:

German Research Sponsors:

		Deutsche Forschungsgemeinschft (DFG) € 34.000

		HelmholtzZentrum München € 500

Charitable Foundation:

José Carreras Leukämie-Stiftung
€ 7.500